Results 201 to 210 of about 214,571 (283)
Abstract Objective Dravet syndrome (DS) is the prototypic developmental and epileptic encephalopathy, characterized by drug‐resistant seizures, developmental slowing, and many other morbidities. Detailed characterization of behavioral phenotypes and social–emotional skill development are limited.
Ingrid E. Scheffer +26 more
wiley +1 more source
Sleep psychoeducation strategies for patients with chronic migraine and sleep quality complaints. [PDF]
Andreis DG +4 more
europepmc +1 more source
Abstract Discussing sudden unexpected death in epilepsy (SUDEP) is difficult and sensitive for health care providers (HCPs), people with epilepsy (PwE), and caregivers. This scoping review examines the literature on SUDEP communication, focusing on need, timing, content, methods, facilitators, barriers, and outcomes. We performed a thematic analysis to
Amir Aschner +5 more
wiley +1 more source
Occupational Risk for Headache Disorders in Female Registered Nurses. A Retrospective Study. [PDF]
D'Ettorre G, Tornese R, Baldassarre A.
europepmc +1 more source
Soticlestat as an adjunctive therapy in children and young adults with Dravet syndrome
Overview of the phase 3 trial evaluating soticlestat as adjunctive therapy in children and young adults with Dravet syndrome. Abstract Objective This study evaluated the efficacy, safety, and tolerability of soticlestat as adjunctive therapy in children and young adults with Dravet syndrome (DS).
Joseph Sullivan +14 more
wiley +1 more source
Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence. [PDF]
Shiju S, Tirumala R, Marseille E.
europepmc +1 more source
Sudden unexpected death in epilepsy (SUDEP): Risk management of pediatric patients with epilepsy
Abstract Objective Sudden unexpected death in epilepsy (SUDEP) is the leading cause of death in people with epilepsy with an incidence of 1:1000. The primary risk factors for SUDEP are generalized or focal to bilateral tonic–clonic seizures. Preventive measures like nighttime monitoring devices and resuscitation training address modifiable risk factors.
Laura Lutz +3 more
wiley +1 more source
Validation of an AI-Based platform for structured diagnosis of headache disorders using ICHD-3 criteria. [PDF]
de Andrade JBC +7 more
europepmc +1 more source

